Explore End-Of-Life care among cancer patients with Alzheimer’s Disease and Related Dementias

Background: End-of-Life (EOL) care aims to reduce pain and limit aggressive intervention for those individuals with terminal illness through the period before death. It is particularly crucial for older persons with cancer. Aggressive EOL care is associated with sub-optimal quality of life for patients and increased expenditures for healthcare payers. In recent years, the incidence of Alzheimer’s Disease and Related Dementias (ADRD) among older persons with cancer has been rising. In addition, having ADRD gradually compromises their physical and mental status, communication skills, and cognitive functions. As the result of having ADRD, arranging EOL care for older persons with both conditions could become extremely challenging and costly. However, little is known about the aggressive EOL care patterns as well as expenditures on EOL care in older persons with both cancer and ADRD. Thus, this dissertation explored the EOL care patterns and estimated the Medicare expenditures of the EOL care in this patient group. Method: This dissertation consisted of two retrospective cohort studies using the 2004 to 2016 Surveillance, Epidemiology, and End Results-Medicare (SEER-Medicare) data. The case cohort was beneficiaries with both cancer and ADRD, the control cohort was beneficiaries with cancer. A one-to-one Greedy Nearest Neighbor propensity score matching method was used to create the balanced non-ADRD group for the statistical analyses. Included beneficiaries were diagnosed with cancer (breast-female only, lung, colorectal, or prostate) and died between January 1st, 2005, and December 31st, 2016. They needed to continuously enroll in traditional Medicare for their last twelve months of life. For calculating EOL care spending, beneficiaries were also required to survive at least twelve months. The first study aimed to assess the quality of EOL care via established claim-based aggressive EOL care indicators. Multivariable logistic regression models were deployed to estimate the odds of receiving any aggressive EOL care. The second study estimated beneficiaries’ Medicare expenditure on EOL care. Generalized Estimating Equation Model was deployed to estimate the monthly Medicare expenditure for the last twelve months of life and Generalized Linear Models were constructed to assess the total EOL care expenditure. Results: Having ADRD attenuated older persons with cancer’s odds of utilizing any aggressive EOL care (AOR: 0.87, 95% CI: 0.85, 0.89) but resulted in consuming slightly more Medicare expenditures during EOL ($64,962.2 vs. $63,966.0, p=0.02) compared to those without ADRD. Also, over 50% of both beneficiary groups had aggressive EOL care utilization history. Higher odds of receiving aggressive EOL care were associated with beneficiaries who were minorities, had shorter overall survival, and had more comorbidity conditions. As for total Medicare spending, beneficiaries with ADRD had around 4% more in their last twelve months of life than those without ADRD. Specifically, Medicare spent more on inpatient services (7%), skilled nursing facility (130%), home health (44%), and hospice (26%) for beneficiaries with cancer and ADRD versus those without ADRD. Conclusion: Beneficiaries with both cancer and ADRD were unlikely to utilize aggressive EOL care; however, the prevalence difference of aggressive EOL care between study groups was not hugely wide. Beneficiaries with both cancer and ADRD tended to spend significantly more healthcare resources during the last twelve months of life, also certain types of care paid by Medicare had much higher spending on those individuals. Sensitivity analyses also underscored the potential effects of severity of ADRD on influencing the EOL care patterns and Medicare expenditures. This study provided recent characterizations of EOL care patterns as well as the estimations of EOL care cost for healthcare systems and providers to reference. Future health behavior intervention studies/EOL care programs are needed to alleviate the risks of utilizing aggressive EOL care and reduce its financial burden.

Files

Metadata

Work Title Explore End-Of-Life care among cancer patients with Alzheimer’s Disease and Related Dementias
Access
Open Access
Creators
  1. Xingran Weng
  2. Chan Shen
  3. Lauren J Van Scoy
  4. Marie Boltz
  5. Monika Joshi
  6. Li Wang
Keyword
  1. End-of-Life
  2. SEER-Medicare
  3. Medicare
  4. Cancer
  5. Alzheimer’s Disease
  6. Dementia
License In Copyright (Rights Reserved)
Work Type Dissertation
Acknowledgments
  1. This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare database.
Publication Date April 11, 2022
Deposited April 11, 2022

Versions

Analytics

Collections

This resource is currently not in any collection.

Work History

Version 1
published

  • Created
  • Updated
  • Updated
  • Added Creator Xingran Weng
  • Added Creator Chan Shen
  • Added Creator Lauren J Van Scoy
  • Added Creator Marie Boltz
  • Added Creator Monika Joshi
  • Added Creator Li Wang
  • Updated Acknowledgments Show Changes
    Acknowledgments
    • This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare database.
  • Added Xingran_Weng_DrPH_Dissertation_ScholarSphere_Submission.pdf
  • Updated Publication Date, License Show Changes
    Publication Date
    • 2022-04-11
    License
    • https://creativecommons.org/licenses/by-nc-nd/4.0/
  • Updated License Show Changes
    License
    • https://creativecommons.org/licenses/by-nc-nd/4.0/
    • https://rightsstatements.org/page/InC/1.0/
  • Updated License Show Changes
    License
    • https://rightsstatements.org/page/InC/1.0/
    • https://creativecommons.org/licenses/by/4.0/
  • Updated License Show Changes
    License
    • https://creativecommons.org/licenses/by/4.0/
    • https://rightsstatements.org/page/InC/1.0/
  • Updated License Show Changes
    License
    • https://rightsstatements.org/page/InC/1.0/
    • https://creativecommons.org/licenses/by/4.0/
  • Deleted Creator Chan Shen
  • Deleted Creator Lauren J Van Scoy
  • Deleted Creator Marie Boltz
  • Deleted Creator Monika Joshi
  • Deleted Creator Li Wang
  • Added Creator Chan Shen
  • Added Creator Lauren J Van Scoy
  • Added Creator Marie Boltz
  • Added Creator Monika Joshi
  • Added Creator Li Wang
  • Updated License Show Changes
    License
    • https://creativecommons.org/licenses/by/4.0/
    • https://rightsstatements.org/page/InC/1.0/
  • Published
  • Updated